3d Biopsy Articles & Analysis: Older
1 news found
The strategic equity round, which was oversubscribed by 150%, comes after the launch of VelacurTM, the first handheld 3D liver health assessment solution, in the US market in early 2021. Cleared by the FDA, VelacurTM is a handheld, point of care ultrasound solution that quantifies liver stiffness using technology similar to MRI elastography combined with 3D ...